QSAR OF ACYL ALIZARIN RED BIOCOMPOUND DERIVATIVES OF RUBIA TINCTORUM ROOTS AND ITS ADMET PROPERTIES AS ANTI-BREAST CANCER CANDIDATES AGAINST MMP-9 PROTEIN RECEPTOR: IN SILICO STUDY

Mochamad R.T. Alifiansyah, Mochammad A. Herdiansyah, Rahma C. Pratiwi, Ragil P. Pramesti, Nisriena W. Hafsyah, Athaya P. Rania, Justitia E.R.P. Putra, Putri A. Cahyono, Litazkiyyah, Sirojuddin K. Muhammad, Ahmad A.A. Murtadlo, Viol D. Kharisma, Arif N.M. Ansori, Vikash Jakhmola, Praveen K. Ashok, Jyoti M. Kalra, Hery Purnobasuki, Intan Ayu Pratiwi

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Alizarin is a polycyclic compound isolated from roots of Rubia tinctorum that has potential as a breast anticancer candidate. Increasing anticancer activity can be done through structural modification to produce derivatives in the form of group substitution in the meta position using acyl. The purpose of this work is to forecast the anticancer activity of alizarin and its derivatives on the MMP-9 receptor using. Important biological activity factors will be identified by Quantitative Structure Activity molecular docking Relationship (QSAR) and projected absorption, distribution, metabolism, elimination, and toxicity (ADMET). Using Molegro Virtual Docker (MVD), molecular docking was carried out on the MMP 9 receptor (4WZV.pdb). LogP, Etot, and MR are the physicochemical parameters that are examined in order to produce QSAR. Statistical Package for the Social Science (SPSS) was used for the QSAR analysis. The pkCSM was utilized to determine ADMET prediction. The acyl alizarin derivatives have a lower rerank score than alizarin, according to the docking results so that they are predicted to have more potent anticancer activity. The QSAR analysis’s findings indicated that logP and Etot had the greatest effects on the alizarin compound’s and its derivatives’ activity. The results of the ADMET prediction indicate that acyl alizarin is less harmful and superior to alizarin. Research findings show that it is possible to synthesize acyl alizarin derivatives, especially alizarin octanoate, which will then be tested in vitro or in vivo to determine its anti-breast cancer activity and toxicity.

Original languageEnglish
Pages (from-to)312-320
Number of pages9
JournalPisevye Sistemy/Food Systems
Volume7
Issue number2
DOIs
Publication statusPublished - 2024

Keywords

  • ADMET prediction
  • alizarin derivatives
  • breast cancer
  • medicine
  • QSAR

Fingerprint

Dive into the research topics of 'QSAR OF ACYL ALIZARIN RED BIOCOMPOUND DERIVATIVES OF RUBIA TINCTORUM ROOTS AND ITS ADMET PROPERTIES AS ANTI-BREAST CANCER CANDIDATES AGAINST MMP-9 PROTEIN RECEPTOR: IN SILICO STUDY'. Together they form a unique fingerprint.

Cite this